Balaxi Pharmaceuticals Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 65.99% of Balaxi Pharmaceuticals, FIIs hold 0.00%, DIIs hold 2.56% and the public holds 31.45%. Promoter holding was unchanged from Jun 2026.
Get an alert when Balaxi Pharmaceuticals reports results or its shareholding changes. Free account.
Promoters
65.99%
unchanged QoQ
FIIs
0.00%
unchanged QoQ
DIIs
2.56%
unchanged QoQ
Public
31.45%
unchanged QoQ
Balaxi Pharmaceuticals shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 65.99% | 0.00% | 2.56% | 31.45% | 14,474 |
| Jun 2026 | 65.99% | 0.00% | 2.56% | 31.45% | 14,682 |
| Mar 2026 | 65.99% | 0.00% | 2.56% | 31.45% | 15,176 |
| Dec 2025 | 65.99% | 1.74% | 0.02% | 32.24% | 15,085 |
| Sep 2025 | 65.99% | 3.50% | 0.02% | 30.49% | 14,620 |
| Jun 2025 | 65.99% | 8.87% | 0.02% | 25.12% | 13,737 |
| Mar 2025 | 65.99% | 16.02% | 0.02% | 17.96% | 9,994 |
| Dec 2024 | 65.99% | 16.48% | 0.02% | 17.50% | 8,529 |
| Sep 2024 | 65.99% | 16.48% | 0.02% | 17.50% | 7,863 |
| Jun 2024 | 65.99% | 16.88% | 0.02% | 17.11% | 6,586 |
| Mar 2024 | 66.86% | 17.21% | 0.02% | 15.91% | 5,206 |
| Dec 2023 | 71.22% | 18.57% | 0.03% | 10.18% | 5,045 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹129 cr, the promoter group's 65.99% stake is worth ₹85 cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Balaxi Pharmaceuticals shareholding: common questions
What is the promoter holding in Balaxi Pharmaceuticals?
Promoters hold 65.99% of Balaxi Pharmaceuticals as of Sep 2026. Their stake was unchanged from Jun 2026.
How much do FIIs hold in Balaxi Pharmaceuticals?
Foreign institutional investors (FIIs) held 0.00% of Balaxi Pharmaceuticals in Sep 2026, unchanged versus Jun 2026.
How much do mutual funds and other DIIs hold in Balaxi Pharmaceuticals?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 2.56% of Balaxi Pharmaceuticals in Sep 2026, unchanged versus Jun 2026.
Is the promoter holding in Balaxi Pharmaceuticals pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Balaxi Pharmaceuticals.
How has Balaxi Pharmaceuticals's promoter holding changed in the last year?
Promoter holding moved from 65.99% in Sep 2025 to 65.99% in Sep 2026 (unchanged).
How many shareholders does Balaxi Pharmaceuticals have?
Balaxi Pharmaceuticals had 14,474 shareholders in Sep 2026, compared with 14,682 in Jun 2026.